This company has been marked as potentially delisted and may not be actively trading. NantKwest (NK) Competitors Add Compare Share Share Competitors Stock AnalysisCompetitorsTrendsBuy This Stock NK vs. NVAX, XFOR, VIR, AVXL, LENZ, REPL, IMTX, VECT, VALN, and OPTShould you be buying NantKwest stock or one of its competitors? The main competitors of NantKwest include Novavax (NVAX), X4 Pharmaceuticals (XFOR), Vir Biotechnology (VIR), Anavex Life Sciences (AVXL), LENZ Therapeutics (LENZ), Replimune Group (REPL), Immatics (IMTX), VectivBio (VECT), Valneva (VALN), and Opthea (OPT). These companies are all part of the "medical" sector. NantKwest vs. Novavax X4 Pharmaceuticals Vir Biotechnology Anavex Life Sciences LENZ Therapeutics Replimune Group Immatics VectivBio Valneva Opthea Novavax (NASDAQ:NVAX) and NantKwest (NASDAQ:NK) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their profitability, earnings, institutional ownership, community ranking, analyst recommendations, risk, dividends, media sentiment and valuation. Do analysts rate NVAX or NK? Novavax presently has a consensus price target of $18.00, suggesting a potential upside of 180.81%. Given Novavax's stronger consensus rating and higher possible upside, analysts clearly believe Novavax is more favorable than NantKwest.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Novavax 1 Sell rating(s) 2 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 2.43NantKwest 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Is NVAX or NK more profitable? Novavax has a net margin of -32.18% compared to NantKwest's net margin of -76,658.58%. Novavax's return on equity of 0.00% beat NantKwest's return on equity.Company Net Margins Return on Equity Return on Assets Novavax-32.18% N/A -17.05% NantKwest -76,658.58%-56.06%-46.93% Does the media prefer NVAX or NK? In the previous week, Novavax had 18 more articles in the media than NantKwest. MarketBeat recorded 18 mentions for Novavax and 0 mentions for NantKwest. Novavax's average media sentiment score of 0.32 beat NantKwest's score of 0.00 indicating that Novavax is being referred to more favorably in the media. Company Overall Sentiment Novavax Neutral NantKwest Neutral Which has higher earnings and valuation, NVAX or NK? NantKwest has lower revenue, but higher earnings than Novavax. Novavax is trading at a lower price-to-earnings ratio than NantKwest, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioNovavax$682.16M1.51-$545.06M-$1.33-4.82NantKwest$40K6,943.41-$65.79M-$0.70-3.63 Do institutionals and insiders believe in NVAX or NK? 53.0% of Novavax shares are owned by institutional investors. Comparatively, 9.4% of NantKwest shares are owned by institutional investors. 1.0% of Novavax shares are owned by insiders. Comparatively, 71.7% of NantKwest shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term. Which has more volatility and risk, NVAX or NK? Novavax has a beta of 3.15, indicating that its share price is 215% more volatile than the S&P 500. Comparatively, NantKwest has a beta of 2.61, indicating that its share price is 161% more volatile than the S&P 500. Does the MarketBeat Community favor NVAX or NK? Novavax received 578 more outperform votes than NantKwest when rated by MarketBeat users. Likewise, 74.06% of users gave Novavax an outperform vote while only 49.19% of users gave NantKwest an outperform vote. CompanyUnderperformOutperformNovavaxOutperform Votes85174.06% Underperform Votes29825.94% NantKwestOutperform Votes27349.19% Underperform Votes28250.81% SummaryNovavax beats NantKwest on 14 of the 18 factors compared between the two stocks. Get NantKwest News Delivered to You Automatically Sign up to receive the latest news and ratings for NK and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NK vs. The Competition Export to ExcelMetricNantKwestBiological Products, Except Diagnostic IndustryMedical SectorNASDAQ ExchangeMarket Cap$277.74M$2.98B$5.56B$8.03BDividend YieldN/A1.87%5.36%4.23%P/E Ratio-3.5830.5222.8118.90Price / Sales6,943.41497.05406.35106.96Price / CashN/A168.6838.1834.62Price / Book2.073.236.794.34Net Income-$65.79M-$71.70M$3.23B$248.27M NantKwest Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NKNantKwestN/A$2.54+2.0%N/A-71.7%$277.74M$40,000.00-3.58160Gap UpHigh Trading VolumeNVAXNovavax3.6121 of 5 stars$6.70+0.4%$18.00+168.7%+30.0%$1.08B$682.16M-2.961,990Upcoming EarningsXFORX4 Pharmaceuticals4.0757 of 5 stars$5.34-6.3%$85.00+1,491.8%-89.2%$927.36M$2.56M-59.3380Earnings ReportAnalyst ForecastStock SplitAnalyst RevisionNews CoverageGap UpHigh Trading VolumeVIRVir Biotechnology2.8967 of 5 stars$6.10-0.3%$33.57+450.4%-40.7%$842.19M$63.71M-1.56580News CoveragePositive NewsAVXLAnavex Life Sciences3.7967 of 5 stars$9.58+1.7%$44.00+359.3%+143.1%$814.91MN/A-17.4240Upcoming EarningsNews CoveragePositive NewsLENZLENZ Therapeutics2.0127 of 5 stars$27.27+1.5%$46.60+70.9%+79.3%$751.10MN/A-5.72110News CoveragePositive NewsREPLReplimune Group4.21 of 5 stars$9.27+2.4%$19.43+109.6%+44.0%$713.93MN/A-3.02210Positive NewsHigh Trading VolumeIMTXImmatics2.1204 of 5 stars$4.77+5.5%$16.67+249.4%-51.4%$579.79M$155.84M-7.23260News CoveragePositive NewsVECTVectivBioN/A$16.85flatN/AN/A$573.24M$27.34M0.0030High Trading VolumeVALNValneva2.5523 of 5 stars$6.57-6.5%$16.00+143.5%-14.8%$549.49M$169.58M-50.54700Upcoming EarningsGap DownOPTOpthea0.839 of 5 stars$3.41+7.2%$1.33-60.9%N/A$524.84M$87,666.000.008News CoverageGap Up Related Companies and Tools Related Companies NVAX Alternatives XFOR Alternatives VIR Alternatives AVXL Alternatives LENZ Alternatives REPL Alternatives IMTX Alternatives VECT Alternatives VALN Alternatives OPT Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:NK) was last updated on 5/4/2025 by MarketBeat.com Staff From Our PartnersWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredTrump to redistribute trillions of dollars Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | Sponsored"I'm risking my reputation on this"I've stayed quiet for too long, but after everything I've uncovered about what's brewing in the 2025 crypto ma...Crypto 101 Media | SponsoredIf you missed your chance with Tesla...Elon Musk is moments from launching a revolutionary technology some Silicon Valley insiders are calling "The F...Brownstone Research | SponsoredShocking AI play that’s beats Nvidia by a country mileYou’ve seen the headlines about Nvidia. Now Tim Sykes is sounding the alarm — because what CEO Jensen Huang is...Timothy Sykes | SponsoredWill May start the next "Great Depression?"You probably haven't heard about this yet... But this could be the biggest wealth building opportunity of t...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NantKwest, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share NantKwest With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy NK Stock Free NK Stock Alerts